In Berger Montague Whistleblower Case, Janssen Found Liable for Illegal Off-Label Promotion and Marketing of Two HIV/AIDS-Treatment Drugs – Judgment Could Exceed $1B

PHILADELPHIA, June 17, 2024 /PRNewswire/ — Berger Montague PC is pleased to announce that on June 13, 2024, a jury unanimously found Johnson & Johnson subsidiary Janssen Products, LP liable for illegal off-label promotion and marketing of two of its HIV/AIDS-treatment drugs, in violation…